RLMD
Relmada Therapeutics, Inc. · Healthcare
CFO Maged Shenouda bought $150K of Relmada Therapeutics, Inc.
Bought$149,701
$2.80Price
53,432Shares
+153%Stake
What RLMD did for a copier
- $1,000 copied at Wed, Sep 11 close, $3.02
- $1,190
- S&P 500, same days
- +4.6%
Measured over 30 trading days, to the Oct 23 close.
Maged Shenouda's record
4 other buys with 3 months of prices since 2019: on average +18.8% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Sep 9. Filed Wed, Sep 11, 1:46 PM ET, during the session. Returns use the Sep 11 close and the Oct 23 close. Not investment advice.